<![CDATA[FDA Approves At-Home Starting Dose of Lecanemab for Treatment of Alzheimer Disease]]>
Read the full articleYou might also wanna read
FDA clears at-home start dose for Alzheimer's drug Leqembi
FDA clears at-home start dose for Alzheimer's drug Leqembi Phil.Taylor Tue, 14/07/2026 - 08:36
FDA approves at-home starter dose of Eisai-Biogen Alzheimer’s drug
(Refiles to add media packaging code, USA-HEALTH/ALZHEIMERS; no change to text or headline) July 13 (Reuters) - The U.S. FDA on Monday appro
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in t
Canada's Drug Agency recommends funding lecanemab for early-stage Alzheimer's disease
Canada's Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzheimer's dis
Canada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease
TORONTO - Canada's Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzhe
Canada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease
TORONTO - Canada's Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzhe
Comments
Sign in to join the conversation.
No comments yet. Be the first.